The recent disruptions in global supply have highlighted the necessity of securing critical medications like Ivermectin. Trusting on overseas producers exposes nations to potential vulnerabilities, including delivery delays, price fluctuations, and even geopolitical threats. Shifting towards domestic procurement of Ivermectin offers a multitude of